Personalized Transplant Care
Through Precision Medicine
The Cutting Edge of Transplant Management
Your transplant team is focused on maintaining the health of your donor organ. Make sure they have the most advanced tools for the job. The Molecular Microscope® Diagnostic System (MMDx) will provide them with more precise information, smarter analysis, and unequivocal results, helping them to make better decisions and prolong your transplant’s functional life.
What is MMDx?
MMDx is the future of transplant management. This technology can detect injury to your transplant at the molecular level and allows your clinicians to rapidly target treatment to your individual needs.
MMDx Helps Assess Transplant Injury and Rejection
When your transplant runs into problems, the cause may be difficult for your clinician to identify using conventional investigatory strategies. These strategies often require a lot of subjective interpretation, and your clinical teams may disagree on the outcomes of these tests. Without a clear understanding of the cause, your clinical team may not be able to design a personalized treatment plan.
MMDx is a molecular test that uses advanced automated analysis, meaning it can identify the precise nature of your transplant injury, which allows your doctor to design the most effective treatment method.
What are the Key Benefits?
-
Requires a small biopsy sample making this process minimally invasive
-
Measures the probability of organ transplant success
-
Biopsy samples compared to other prevalent global transplant population
How Does MMDx Work?
mRNA is produced inside
transplanted tissue when DNA genes are expressed or active.
Depending on the risk or severity of organ rejection and injury, particular genes will be activated and produce unique patterns of mRNA.
MMDx accurately analyzes
thousands of different mRNA to provide you and your doctor precise information about the health of your transplanted organ to create a personalized treatment plan.